President and Chief Executive Officer and Director · ANAPTYSBIO, INC (ANAB)

Daniel Faga

A named executive officer of ANAPTYSBIO in every fiscal year CompBrief holds from FY2022 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$6,133,943

FY2024: $13,630,292

1st of 3 named executive officers at Anaptysbio by FY2025 total.

3 named officers on file for ANAPTYSBIO, FY2025

See an example →

What this number hides

The filing gives the total. ANAPTYSBIO’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed June 29, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-07.

Free

Get Daniel Faga’s full pay file as a PDF — free

More than this page: up to 10 years of Daniel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Daniel Faga and every company like it: Velarion Intel, free for 3 days, no card →

Daniel Faga compensation by year

ANAPTYSBIO Summary Compensation Table · all 4 fiscal years held
In US dollars, as ANAPTYSBIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024FY2025
Salary$483,578$640,605$685,448$706,011
Bonus$0$0$0$0
Stock awards$23,506,640$1,658,622$6,889,127$1,592,001
Option awards$200,618$3,287,320$5,723,455$3,345,653
Non-equity incentive$240,609$352,333$308,452$465,968
Pension and deferred compensation$0$0$0$0
All other$8,905$1,523,040$23,810$24,310
Total$24,440,350$7,461,920$13,630,292$6,133,943

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ANAPTYSBIO, INC DEF 14A filed June 29, 2026, accession 0001193125-26-288408, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ANAPTYSBIO, INC filed document, accession 0001193125-26-288408. Every figure is read from that document and cited to the page and table it appears in. Filed June 29, 2026.

$24.4M
$7.5M
$13.6M
$6.1M
FY22
FY23
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU160,000$7,756,800—
RSU107,350$5,204,328—
RSU104,032$5,043,471—
RSU35,700$1,730,736—
Option197,719—$21.19
Option52,785—$23.23
Option305,500—$14.83

Per the Outstanding Equity Awards at Fiscal Year-End table in ANAPTYSBIO, INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2025 proxy (filed June 29, 2026)
current to 2026-11-07 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-03-12Grant or award derivative—53,334$0.0053,334

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ANAPTYSBIO’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Daniel Faga · this pagePresident and Chief Executive Officer and Director$6,133,943
Paul LizzulChief Medical Officer$2,365,377
Dennis MulroyChief Financial Officer$2,007,927

Board service

ANAPTYSBIO board · FY2021–FY2025
Director compensation in US dollars, as ANAPTYSBIO reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$0$0—
FY2024—————
FY2023—————
FY2021$3,913—$305,816—$309,729

Each year as the company reported it in ANAPTYSBIO's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: ANAPTYSBIO pays directors a $40,000 cash retainer. As stated in ANAPTYSBIO's FY2025 proxy.

The full ANAPTYSBIO compensation record

free company brief

This page is one person within ANAPTYSBIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ANAPTYSBIO's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ANAPTYSBIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order ANAB

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Daniel Faga's compensation dossier